
Consun Pharmaceutical Group Ltd
HKEX:1681

Wall Street
Price Targets
Price Targets Summary
Consun Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for
Consun Pharmaceutical Group Ltd
is 12.19 HKD
with a low forecast of 10.1 HKD and a high forecast of 14.6 HKD.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Consun Pharmaceutical Group Ltd
For the last 8 years the
compound annual growth rate for
Consun Pharmaceutical Group Ltd's operating income is
12%.
The projected
CAGR
for the next 3 years is
15%.
Net Income
Forecast
Net Income Estimate
Consun Pharmaceutical Group Ltd
For the last 8 years the
compound annual growth rate for
Consun Pharmaceutical Group Ltd's net income is
15%.
The projected
CAGR
for the next 3 years is
14%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Consun Pharmaceutical Group Ltd's stock price target?
Price Target
12.19
HKD
According to Wall Street analysts, the average 1-year price target for
Consun Pharmaceutical Group Ltd
is 12.19 HKD
with a low forecast of 10.1 HKD and a high forecast of 14.6 HKD.
What is Consun Pharmaceutical Group Ltd's Revenue forecast?
Projected CAGR
13%
For the last 8 years the
compound annual growth rate for
Consun Pharmaceutical Group Ltd's revenue is
12%.
The projected
CAGR
for the next 3 years is
13%.
What is Consun Pharmaceutical Group Ltd's Operating Income forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
Consun Pharmaceutical Group Ltd's operating income is
12%.
The projected
CAGR
for the next 3 years is
15%.
What is Consun Pharmaceutical Group Ltd's Net Income forecast?
Projected CAGR
14%
For the last 8 years the
compound annual growth rate for
Consun Pharmaceutical Group Ltd's net income is
15%.
The projected
CAGR
for the next 3 years is
14%.